As of 2025-03-19, the EV/EBITDA ratio of Apyx Medical Corp (APYX) is -2.35. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Apyx's latest enterprise value is 49.32 mil USD. Apyx's TTM EBITDA according to its financial statements is -20.96 mil USD. Dividing these 2 quantities gives us the above Apyx EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 20.6x | 19.0x |
| Forward P/E multiples | 20.7x - 21.4x | 21.0x |
| Fair Price | (10.85) - (10.78) | (10.48) |
| Upside | -1113.9% - -1107.1% | -1079.1% |
| Date | EV/EBITDA |
| 2025-03-14 | -2.22 |
| 2025-03-13 | -2.29 |
| 2025-03-12 | -2.35 |
| 2025-03-11 | -2.34 |
| 2025-03-10 | -2.45 |
| 2025-03-07 | -2.59 |
| 2025-03-06 | -2.57 |
| 2025-03-05 | -2.60 |
| 2025-03-04 | -2.59 |
| 2025-03-03 | -2.84 |
| 2025-02-28 | -3.09 |
| 2025-02-27 | -2.95 |
| 2025-02-26 | -3.05 |
| 2025-02-25 | -3.03 |
| 2025-02-24 | -3.05 |
| 2025-02-21 | -3.20 |
| 2025-02-20 | -3.10 |
| 2025-02-19 | -3.16 |
| 2025-02-18 | -3.19 |
| 2025-02-14 | -3.19 |
| 2025-02-13 | -2.99 |
| 2025-02-12 | -2.91 |
| 2025-02-11 | -2.99 |
| 2025-02-10 | -3.05 |
| 2025-02-07 | -3.01 |
| 2025-02-06 | -2.97 |
| 2025-02-05 | -3.15 |
| 2025-02-04 | -3.06 |
| 2025-02-03 | -3.03 |
| 2025-01-31 | -3.07 |
| 2025-01-30 | -3.22 |
| 2025-01-29 | -3.11 |
| 2025-01-28 | -3.07 |
| 2025-01-27 | -3.03 |
| 2025-01-24 | -3.17 |
| 2025-01-23 | -3.24 |
| 2025-01-22 | -3.22 |
| 2025-01-21 | -3.24 |
| 2025-01-17 | -2.97 |
| 2025-01-16 | -3.03 |
| 2025-01-15 | -3.03 |
| 2025-01-14 | -3.05 |
| 2025-01-13 | -3.17 |
| 2025-01-10 | -3.36 |
| 2025-01-08 | -3.28 |
| 2025-01-07 | -3.59 |
| 2025-01-06 | -3.61 |
| 2025-01-03 | -3.49 |
| 2025-01-02 | -3.33 |
| 2024-12-31 | -3.34 |